BiotechTube
Home/NeuroDex/Erez Eitan
EE

Erez Eitan

CEO and CSO

NeuroDex

Therapeutic Areas

Parkinson's DiseaseAlzheimer's DiseaseAmyotrophic Lateral Sclerosis (ALS)Frontotemporal DementiaNeuroinflammationBrain Injury

NeuroDex Pipeline

DrugIndicationPhase
α-Syn Biomarker ProgramParkinson's, MSA, Alzheimer'sPre-clinical
TDP43 Biomarker ProgramALS, FTD, Alzheimer'sPre-clinical
Tau/pTau Biomarker ProgramAlzheimer's DiseasePre-clinical
NF-L Biomarker ProgramBrain injury and neuroinflammationPre-clinical
Biomarker Discovery & Validation ServicesNeurological disordersService
Clinical Trial Biomarker SupportNeurological disordersService

Leadership Team at NeuroDex

VA
Victoria Akhiezer
COO
OV
Olga Volpert
Senior Director of Assay Development
MM
Michael McKenna
CDO
View full NeuroDex profile